Plasma and synovial fluid concentrations of salicylic acid and its metabolites in patients with joint effusions.
Equilibration of salicylic, salicyluric and gentisic acids between plasma and synovial fluid (SF) was measured in 36 patients receiving chronic salicylate therapy and from whom SF was required for diagnostic purposes. Gentisic and salicyluric acids equilibrated completely, while SF salicylic acid concentration was less than that in plasma. The presence of significant gentisic acid concentrations in SF could contribute to the therapeutic response to chronic salicylate therapy, since its antiinflammatory effect is even greater than that of acetylsalicylic acid.
D000328:Adult; D000368:Aged; D001168:Arthritis / Q000097:blood / Q000188:drug therapy / Q000378:metabolism*; D001241:Aspirin / Q000627:therapeutic use; D005260:Female; D005841:Gentisates; D006626:Hippurates / Q000097:blood / Q000378:metabolism; D006801:Humans; D062385:Hydroxybenzoates / Q000097:blood / Q000378:metabolism; D008297:Male; D008875:Middle Aged; D012459:Salicylates / Q000097:blood / Q000378:metabolism*; D020156:Salicylic Acid; D013582:Synovial Fluid / Q000378:metabolism*
D005841:Gentisates; D006626:Hippurates; D062385:Hydroxybenzoates; D012459:Salicylates; C000693:salicylurate; D020156:Salicylic Acid; D001241:Aspirin; C010925:2,5-dihydroxybenzoic acid